The only thing SIERRA was good for was a reminder of the HUNDREDS OF MILLIONS of dollars spent by Roche and Pfizer in the past on FAILED research to find a way to activate p53. 
If KEVETRIN "WORKS", and we believe it will, then "YES" they will have some interest in CTIX. ,